Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_assertion type Assertion NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_head.
- NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_assertion description "[Furthermore, inhibiting ERK1/2 and p38 efficiently blocks C5a-mediated Fgl2 production during viral infections.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_provenance.
- NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_assertion evidence source_evidence_literature NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_provenance.
- NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_assertion SIO_000772 24604562 NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_provenance.
- NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_assertion wasDerivedFrom befree-20150227 NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_provenance.
- NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_assertion wasGeneratedBy ECO_0000203 NP848308.RAVSfpS22_GSrGKJ4r-CTBxdcaiMjWrzOl3jO3K1VLF-g130_provenance.